S6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning
Update: 2025-04-15
Description
In this episode of Emerging Experts, Xiaojie Zhang, MD, a hematology/oncology fellow, and Akshat Singhal, PhD, a postdoctoral scholar, both at UC San Diego, shed light on innovative research leveraging deep learning to predict how patients with ER-positive/HER2-negative (ER+/HER2-) breast cancer will respond to palbociclib (Ibrance), a common first-line treatment for this patient population. Their work, fueled by the desire to improve precision oncology, demonstrates the significant potential of artificial intelligence (AI) in guiding cancer care.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
